Track HALO and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
HALO - Halozyme Therapeutics Inc (HALO) has a earnings per share of $1.22, up 10.0% over the past year.
Latest EPS (Actual)
$1.22
Beat Rate
75.0%
Most Recent
Miss
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| May 2026 | $1.76 | $1.22 | Miss | -30.61% |
| Feb 2026 | $2.20 | -$0.24 | Miss | -110.91% |
| Nov 2025 | $1.63 | $1.72 | Beat | +5.52% |
| Aug 2025 | $1.27 | $1.54 | Beat | +21.26% |
| May 2025 | $0.95 | $1.11 | Beat | +16.84% |
| Feb 2025 | $1.16 | $1.26 | Beat | +8.73% |
| Oct 2024 | $0.98 | $1.27 | Beat | +29.59% |
| Aug 2024 | $0.76 | $0.91 | Beat | +19.74% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.